Alligator Bioscience is identified as a clinical-stage biotechnology company.
Steady: 0 in the last 7 days
Updated nov 3
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alligator Bioscience is identified as a clinical-stage biotechnology company.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Lars Bergkvist was appointed Chairman of the Nomination Committee at Alligator Bioscience.Sub-event
Alligator Bioscience transferred rights for mitazalimab to Biossil.1 source
Johan Giléus will take over as CEO of Alligator Bioscience, with HLX22 identified as the principal value driver.1 source
Alligator Bioscience is confirmed as a clinical-stage biotech firm.1 source